Werewolf Therapeutics, Inc. (HOWL) Tops Q4 EPS by 14c
Tweet
Share
E-mailGet Alerts HOWL Hot Sheet
Join SI Premium – FREE
Werewolf Therapeutics, Inc. (NASDAQ: HOWL) reported Q4 EPS of ($0.20), $0.14 better than the analyst estimate of ($0.34).
For earnings history and earnings-related data on Werewolf Therapeutics, Inc. (HOWL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Leerink Starts Ligand Pharma (LGND) at Outperform
- Tesla Nears Unveiling of Radical New ‘Flying’ Roadster - The Information
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
